Cordycepin induces human lung cancer cell apoptosis by inhibiting nitric oxide mediated ERK/Slug signaling pathway

Jung Hoo Hwang, Soo Jung Park, Won Gyu Ko, Seong Mun Kang, Da Bin Lee, Junho Bang, Byung Joo Park, Chung Beum Wee, Dae Joon Kim, Ik Soon Jang, Jae Hong Ko

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Nitric oxide (NO) is an important signaling molecule and a component of the inflammatory cascade. Besides, it is also involved in tumorigenesis. Aberrant upregulation and activation of the ERK cascade by NO often leads to tumor cell development. However, the role of ERK inactivation induced by the negative regulation of NO during apoptosis is not completely understood. In this study, treatment of A549 and PC9 human lung adenocarcinoma cell lines with cordycepin led to a reduction in their viability. Analysis of the effect of cordycepin treatment on ERK/Slug signaling activity in the A549 cell line revealed that LPS-induced inflammatory microenvironments could stimulate the expression of TNF-α, CCL5, IL-1β, IL-6, IL-8 and upregulate NO, phospho-ERK (p-ERK), and Slug expression. In addition, constitutive expression of NO was observed. Cordycepin inhibited LPS-induced stimulation of iNOS, NO, p-ERK, and Slug expression. L-NAME, an inhibitor of NOS, inhibited p-ERK and Slug expression. It was also found that cordycepin-mediated inhibition of ERK downregulated Slug, whereas overexpression of ERK led to an upregulation of Slug levels in the cordycepin-treated A549 cells. Inhibition of Slug by siRNA induced Bax and caspase-3, leading to cordycepin-induced apoptosis. Cordycepin-mediated inhibition of ERK led to a reduction in phospho-GSK3β (p-GSK3β) and Slug levels, whereas LiCl, an inhibitor of GSK3β, upregulated p-GSK3β and Slug. Overall, the results obtained indicate that cordycepin inhibits the ERK/Slug signaling pathway through the activation of GSK3β which, in turn, upregulates Bax, leading to apoptosis of the lung cancer cells.

Original languageEnglish (US)
Pages (from-to)417-432
Number of pages16
JournalAmerican Journal of Cancer Research
Volume7
Issue number3
StatePublished - 2017
Externally publishedYes

Fingerprint

Gastropoda
Lung Neoplasms
Nitric Oxide
Apoptosis
Up-Regulation
cordycepin
NG-Nitroarginine Methyl Ester
Interleukin-8
Interleukin-1
Caspase 3
Small Interfering RNA
Interleukin-6
Carcinogenesis
Down-Regulation
Cell Line

Keywords

  • Apoptosis
  • Cordycepin
  • ERK
  • Lung cancer
  • Nitric oxide
  • Slug

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hwang, J. H., Park, S. J., Ko, W. G., Kang, S. M., Lee, D. B., Bang, J., ... Ko, J. H. (2017). Cordycepin induces human lung cancer cell apoptosis by inhibiting nitric oxide mediated ERK/Slug signaling pathway. American Journal of Cancer Research, 7(3), 417-432.

Cordycepin induces human lung cancer cell apoptosis by inhibiting nitric oxide mediated ERK/Slug signaling pathway. / Hwang, Jung Hoo; Park, Soo Jung; Ko, Won Gyu; Kang, Seong Mun; Lee, Da Bin; Bang, Junho; Park, Byung Joo; Wee, Chung Beum; Kim, Dae Joon; Jang, Ik Soon; Ko, Jae Hong.

In: American Journal of Cancer Research, Vol. 7, No. 3, 2017, p. 417-432.

Research output: Contribution to journalArticle

Hwang, JH, Park, SJ, Ko, WG, Kang, SM, Lee, DB, Bang, J, Park, BJ, Wee, CB, Kim, DJ, Jang, IS & Ko, JH 2017, 'Cordycepin induces human lung cancer cell apoptosis by inhibiting nitric oxide mediated ERK/Slug signaling pathway', American Journal of Cancer Research, vol. 7, no. 3, pp. 417-432.
Hwang, Jung Hoo ; Park, Soo Jung ; Ko, Won Gyu ; Kang, Seong Mun ; Lee, Da Bin ; Bang, Junho ; Park, Byung Joo ; Wee, Chung Beum ; Kim, Dae Joon ; Jang, Ik Soon ; Ko, Jae Hong. / Cordycepin induces human lung cancer cell apoptosis by inhibiting nitric oxide mediated ERK/Slug signaling pathway. In: American Journal of Cancer Research. 2017 ; Vol. 7, No. 3. pp. 417-432.
@article{0d008c46cc0b4086bf3d4609da3b7095,
title = "Cordycepin induces human lung cancer cell apoptosis by inhibiting nitric oxide mediated ERK/Slug signaling pathway",
abstract = "Nitric oxide (NO) is an important signaling molecule and a component of the inflammatory cascade. Besides, it is also involved in tumorigenesis. Aberrant upregulation and activation of the ERK cascade by NO often leads to tumor cell development. However, the role of ERK inactivation induced by the negative regulation of NO during apoptosis is not completely understood. In this study, treatment of A549 and PC9 human lung adenocarcinoma cell lines with cordycepin led to a reduction in their viability. Analysis of the effect of cordycepin treatment on ERK/Slug signaling activity in the A549 cell line revealed that LPS-induced inflammatory microenvironments could stimulate the expression of TNF-α, CCL5, IL-1β, IL-6, IL-8 and upregulate NO, phospho-ERK (p-ERK), and Slug expression. In addition, constitutive expression of NO was observed. Cordycepin inhibited LPS-induced stimulation of iNOS, NO, p-ERK, and Slug expression. L-NAME, an inhibitor of NOS, inhibited p-ERK and Slug expression. It was also found that cordycepin-mediated inhibition of ERK downregulated Slug, whereas overexpression of ERK led to an upregulation of Slug levels in the cordycepin-treated A549 cells. Inhibition of Slug by siRNA induced Bax and caspase-3, leading to cordycepin-induced apoptosis. Cordycepin-mediated inhibition of ERK led to a reduction in phospho-GSK3β (p-GSK3β) and Slug levels, whereas LiCl, an inhibitor of GSK3β, upregulated p-GSK3β and Slug. Overall, the results obtained indicate that cordycepin inhibits the ERK/Slug signaling pathway through the activation of GSK3β which, in turn, upregulates Bax, leading to apoptosis of the lung cancer cells.",
keywords = "Apoptosis, Cordycepin, ERK, Lung cancer, Nitric oxide, Slug",
author = "Hwang, {Jung Hoo} and Park, {Soo Jung} and Ko, {Won Gyu} and Kang, {Seong Mun} and Lee, {Da Bin} and Junho Bang and Park, {Byung Joo} and Wee, {Chung Beum} and Kim, {Dae Joon} and Jang, {Ik Soon} and Ko, {Jae Hong}",
year = "2017",
language = "English (US)",
volume = "7",
pages = "417--432",
journal = "American Journal of Cancer Research",
issn = "2156-6976",
publisher = "e-Century Publishing Corporation",
number = "3",

}

TY - JOUR

T1 - Cordycepin induces human lung cancer cell apoptosis by inhibiting nitric oxide mediated ERK/Slug signaling pathway

AU - Hwang, Jung Hoo

AU - Park, Soo Jung

AU - Ko, Won Gyu

AU - Kang, Seong Mun

AU - Lee, Da Bin

AU - Bang, Junho

AU - Park, Byung Joo

AU - Wee, Chung Beum

AU - Kim, Dae Joon

AU - Jang, Ik Soon

AU - Ko, Jae Hong

PY - 2017

Y1 - 2017

N2 - Nitric oxide (NO) is an important signaling molecule and a component of the inflammatory cascade. Besides, it is also involved in tumorigenesis. Aberrant upregulation and activation of the ERK cascade by NO often leads to tumor cell development. However, the role of ERK inactivation induced by the negative regulation of NO during apoptosis is not completely understood. In this study, treatment of A549 and PC9 human lung adenocarcinoma cell lines with cordycepin led to a reduction in their viability. Analysis of the effect of cordycepin treatment on ERK/Slug signaling activity in the A549 cell line revealed that LPS-induced inflammatory microenvironments could stimulate the expression of TNF-α, CCL5, IL-1β, IL-6, IL-8 and upregulate NO, phospho-ERK (p-ERK), and Slug expression. In addition, constitutive expression of NO was observed. Cordycepin inhibited LPS-induced stimulation of iNOS, NO, p-ERK, and Slug expression. L-NAME, an inhibitor of NOS, inhibited p-ERK and Slug expression. It was also found that cordycepin-mediated inhibition of ERK downregulated Slug, whereas overexpression of ERK led to an upregulation of Slug levels in the cordycepin-treated A549 cells. Inhibition of Slug by siRNA induced Bax and caspase-3, leading to cordycepin-induced apoptosis. Cordycepin-mediated inhibition of ERK led to a reduction in phospho-GSK3β (p-GSK3β) and Slug levels, whereas LiCl, an inhibitor of GSK3β, upregulated p-GSK3β and Slug. Overall, the results obtained indicate that cordycepin inhibits the ERK/Slug signaling pathway through the activation of GSK3β which, in turn, upregulates Bax, leading to apoptosis of the lung cancer cells.

AB - Nitric oxide (NO) is an important signaling molecule and a component of the inflammatory cascade. Besides, it is also involved in tumorigenesis. Aberrant upregulation and activation of the ERK cascade by NO often leads to tumor cell development. However, the role of ERK inactivation induced by the negative regulation of NO during apoptosis is not completely understood. In this study, treatment of A549 and PC9 human lung adenocarcinoma cell lines with cordycepin led to a reduction in their viability. Analysis of the effect of cordycepin treatment on ERK/Slug signaling activity in the A549 cell line revealed that LPS-induced inflammatory microenvironments could stimulate the expression of TNF-α, CCL5, IL-1β, IL-6, IL-8 and upregulate NO, phospho-ERK (p-ERK), and Slug expression. In addition, constitutive expression of NO was observed. Cordycepin inhibited LPS-induced stimulation of iNOS, NO, p-ERK, and Slug expression. L-NAME, an inhibitor of NOS, inhibited p-ERK and Slug expression. It was also found that cordycepin-mediated inhibition of ERK downregulated Slug, whereas overexpression of ERK led to an upregulation of Slug levels in the cordycepin-treated A549 cells. Inhibition of Slug by siRNA induced Bax and caspase-3, leading to cordycepin-induced apoptosis. Cordycepin-mediated inhibition of ERK led to a reduction in phospho-GSK3β (p-GSK3β) and Slug levels, whereas LiCl, an inhibitor of GSK3β, upregulated p-GSK3β and Slug. Overall, the results obtained indicate that cordycepin inhibits the ERK/Slug signaling pathway through the activation of GSK3β which, in turn, upregulates Bax, leading to apoptosis of the lung cancer cells.

KW - Apoptosis

KW - Cordycepin

KW - ERK

KW - Lung cancer

KW - Nitric oxide

KW - Slug

UR - http://www.scopus.com/inward/record.url?scp=85016256987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016256987&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85016256987

VL - 7

SP - 417

EP - 432

JO - American Journal of Cancer Research

JF - American Journal of Cancer Research

SN - 2156-6976

IS - 3

ER -